Rheumatoid Arthritis Clinical Trial
Official title:
Coping Skills Training for Early Rheumatoid Arthritis
Rheumatoid arthritis (RA) is the most common inflammatory arthritis and a major health problem. Medical treatments are now being used much earlier in the course of RA, but these treatments do not address the challenges of coping with the early stages of this disease. This study will determine whether a comprehensive coping skills training program can decrease pain, psychological disability, and physical disability in patients with early RA.
RA is a serious and complex disease that taxes patients' coping resources. Patients with RA
must cope with pain and with major life stresses, including disruptions in their health,
work, family, and marital functioning.
Recognition of the morbidity and mortality associated with RA has increased interest in early
interventions. Rapid disease progression during the first few years of RA taxes patients'
coping efforts. Those who cope well with the early stages of RA can maintain an active and
rewarding lifestyle. Those who do not may become depressed, decrease physical activity, and
develop a sedentary, restricted lifestyle that contributes to long-term disability and
overdependence on family and friends.
This study will evaluate the effectiveness of early coping skills training (CST) to enhance
self-efficacy, prepare patients to cope with future pain, and prevent the development of
behaviors that may increase long-term psychological distress and physical disability. The
comprehensive CST intervention combines traditional CST with CST components tailored to
rheumatoid arthritis patients. It is designed to teach traditional coping skills such as
attention diversion, cognitive restructuring, and changes in activity to control and decrease
pain.
Participants will be randomized to one of three study groups: 1) comprehensive pain coping
skills training; 2) arthritis education; or 3) standard care. Study participants assigned to
the comprehensive CST and the arthritis education groups will be asked to attend ten weekly,
80-minute treatment sessions. These ten sessions will be followed by a series of six biweekly
follow-up telephone calls.
Study participants in the arthritis education group will learn about the nature and treatment
of rheumatoid arthritis as well as the benefits of exercise and joint protection. Study
participants in the standard care group will continue to receive care from their
rheumatologists but will not participate in any treatment sessions.
Measures of pain, disability, pain coping, and self efficacy will be collected during
evaluation sessions before and after the treatment phase. Participants attend 5 evaluation
sessions and will be followed for 18 months.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |